Bio Financial Statements From 2010 to 2026

BIO Stock  USD 278.25  3.04  1.10%   
Bio Rad's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Bio Rad's valuation are provided below:
Gross Profit
1.3 B
Profit Margin
0.2942
Market Capitalization
7.4 B
Enterprise Value Revenue
3.1118
Revenue
2.6 B
We have found one hundred twenty available fundamental signals for Bio Rad Laboratories, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate Bio Rad's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 27th of February 2026, Market Cap is likely to grow to about 919.2 M. Also, Enterprise Value is likely to grow to about 1 B

Bio Rad Total Revenue

1.45 Billion

Check Bio Rad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Rad's main balance sheet or income statement drivers, such as Depreciation And Amortization of 215.7 M, Interest Expense of 51.5 M or Selling General Administrative of 502.6 M, as well as many indicators such as Price To Sales Ratio of 3.36, Dividend Yield of 0.0 or PTB Ratio of 2.1. Bio financial statements analysis is a perfect complement when working with Bio Rad Valuation or Volatility modules.
  
Build AI portfolio with Bio Stock
Check out the analysis of Bio Rad Correlation against competitors.

Bio Rad Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets11.1 B10.6 B7.4 B
Slightly volatile
Short and Long Term Debt Total1.6 B1.5 B736.2 M
Slightly volatile
Other Current Liabilities199.3 M313.5 M269.9 M
Slightly volatile
Total Current Liabilities348.8 M517 M494.1 M
Slightly volatile
Total Stockholder Equity7.8 B7.5 B5.3 B
Slightly volatile
Property Plant And Equipment Net745.4 M709.9 M541.8 M
Slightly volatile
Retained Earnings8.6 B8.2 B5.1 B
Slightly volatile
Cash269.7 M531.8 M437.6 M
Pretty Stable
Non Current Assets Total8.1 B7.7 B5.3 B
Slightly volatile
Non Currrent Assets Other66.2 M102.3 M79.6 M
Pretty Stable
Cash And Short Term Investments1.6 B1.5 BB
Slightly volatile
Net Receivables283.9 M472.5 M392.4 M
Slightly volatile
Common Stock Shares Outstanding29 M27.3 M28.7 M
Slightly volatile
Liabilities And Stockholders Equity11.1 B10.6 B7.4 B
Slightly volatile
Non Current Liabilities Total2.7 B2.6 B1.7 B
Slightly volatile
Inventory777.7 M740.7 M565.7 M
Slightly volatile
Other Current Assets96.6 M150.3 M138.6 M
Pretty Stable
Total Liabilities3.3 B3.1 B2.2 B
Slightly volatile
Property Plant And Equipment Gross2.1 BB961.5 M
Slightly volatile
Total Current Assets3.1 B2.9 B2.1 B
Slightly volatile
Short Term Debt35.3 M37.9 M43.8 M
Pretty Stable
Accounts Payable93.6 M129 M122.3 M
Pretty Stable
Intangible Assets194.2 M174.3 M215.6 M
Slightly volatile
Common Stock Total Equity2.6 K2.7 K738 K
Slightly volatile
Common Stock2.9 KK738.1 K
Slightly volatile
Long Term Debt1.3 B1.2 B610.6 M
Slightly volatile
Good Will354.9 M579.8 M402.4 M
Very volatile
Property Plant Equipment418.8 M709.9 M494 M
Slightly volatile
Current Deferred Revenue43.2 B41.1 B9.2 B
Slightly volatile
Other Liabilities2.4 B2.3 B1.2 B
Slightly volatile
Short Term Investments1.1 BB578.1 M
Slightly volatile
Net Tangible Assets11.1 B10.6 B5.8 B
Slightly volatile
Capital Surpluse395 M476 M352.6 M
Slightly volatile
Non Current Liabilities Other218 M197.8 M194 M
Slightly volatile
Deferred Long Term Asset Charges15.6 M17.8 M15.5 M
Slightly volatile
Long Term Debt Total642.9 M1.2 B605.3 M
Slightly volatile
Long Term Investments5.3 B6.1 BB
Slightly volatile
Short and Long Term Debt1.2 M1.3 M179.3 M
Slightly volatile
Cash And Equivalents541.3 M529.8 M482.4 M
Slightly volatile
Net Invested Capital7.5 B8.7 B5.4 B
Slightly volatile
Net Working Capital2.1 B2.4 B1.7 B
Slightly volatile
Capital Lease Obligations158.4 M181.8 M202.8 M
Slightly volatile

Bio Rad Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization215.7 M205.4 M144.6 M
Slightly volatile
Selling General Administrative502.6 M844.3 M740.8 M
Slightly volatile
Total Revenue1.4 B2.6 B2.2 B
Slightly volatile
Gross Profit804.7 M1.3 B1.2 B
Slightly volatile
Other Operating Expenses1.3 B2.3 B1.9 B
Slightly volatile
Cost Of Revenue643.6 M1.2 B980.2 M
Slightly volatile
Total Operating Expenses642.9 M1.1 B948.3 M
Slightly volatile
Research Development170.7 M256.9 M212.9 M
Slightly volatile
Minority Interest18 K18.9 K101.6 K
Slightly volatile
Non Operating Income Net Other54.1 M51.5 M23.8 M
Slightly volatile
Non Recurring353.2 M336.4 M187.3 M
Slightly volatile
Interest Income90.7 M95.5 M591.1 M
Pretty Stable
Reconciled Depreciation157.8 M165.4 M146.5 M
Very volatile
Extraordinary Items47.6 M44.1 M58.5 M
Slightly volatile
Selling And Marketing Expenses1.2 M1.3 M1.5 M
Slightly volatile

Bio Rad Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow283.2 M489.8 M461.2 M
Very volatile
Depreciation215.7 M205.4 M140 M
Slightly volatile
Capital Expenditures90 M157.6 M120 M
Slightly volatile
Total Cash From Operating Activities558.8 M532.2 M328.7 M
Slightly volatile
End Period Cash Flow298.9 M532.2 M440 M
Slightly volatile
Change Receivables82.3 M78.4 M34.7 M
Slightly volatile
Cash Flows Other Operating137.9 M145.2 M247.8 M
Very volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.363.19773.2562
Slightly volatile
PTB Ratio2.11.10821.7516
Slightly volatile
Days Sales Outstanding86.5666.763168.2449
Pretty Stable
Book Value Per Share287273182
Slightly volatile
Operating Cash Flow Per Share20.519.52111.4331
Slightly volatile
Stock Based Compensation To Revenue0.02290.02180.0137
Slightly volatile
Capex To Depreciation1.390.76730.9802
Very volatile
PB Ratio2.11.10821.7516
Slightly volatile
EV To Sales3.763.58463.3765
Slightly volatile
Inventory Turnover2.171.67361.8751
Slightly volatile
Days Of Inventory On Hand151218196
Slightly volatile
Payables Turnover5.89.60937.8665
Slightly volatile
Sales General And Administrative To Revenue0.430.420.377
Pretty Stable
Research And Ddevelopement To Revenue0.07620.09950.095
Very volatile
Capex To Revenue0.07010.0610.0564
Very volatile
Cash Per Share59.4256.585835.6766
Slightly volatile
POCF Ratio15.1215.521325.5525
Pretty Stable
Capex To Operating Cash Flow0.280.29610.5211
Slightly volatile
Days Payables Outstanding57.9737.98447.4445
Slightly volatile
EV To Operating Cash Flow17.3717.398826.7886
Pretty Stable
Intangibles To Total Assets0.06770.07130.1189
Slightly volatile
Current Ratio5.95.62134.246
Slightly volatile
Tangible Book Value Per Share258246160
Slightly volatile
Receivables Turnover3.815.46715.3973
Pretty Stable
Graham Number391373321
Slightly volatile
Shareholders Equity Per Share287273182
Slightly volatile
Debt To Equity0.20.20540.217
Slightly volatile
Capex Per Share6.075.78074.3516
Slightly volatile
Revenue Per Share99.4994.751177.8172
Slightly volatile
Interest Debt Per Share60.8557.95426.9358
Slightly volatile
Debt To Assets0.240.14480.1369
Slightly volatile
Short Term Coverage Ratios13.3414.0422417
Very volatile
Operating Cycle294285268
Slightly volatile
Price Book Value Ratio2.11.10821.7516
Slightly volatile
Days Of Payables Outstanding57.9737.98447.4445
Slightly volatile
Price To Operating Cash Flows Ratio15.1215.521325.5525
Pretty Stable
Company Equity Multiplier2.161.4191.5654
Slightly volatile
Long Term Debt To Capitalization0.280.15230.1522
Slightly volatile
Total Debt To Capitalization0.320.17040.1729
Slightly volatile
Debt Equity Ratio0.20.20540.217
Slightly volatile
Quick Ratio4.44.18863.1067
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.763.37692.45
Slightly volatile
Net Income Per E B T0.580.76330.7584
Very volatile
Cash Ratio1.081.02860.8806
Pretty Stable
Cash Conversion Cycle241247224
Slightly volatile
Operating Cash Flow Sales Ratio0.220.2060.1377
Slightly volatile
Days Of Inventory Outstanding151218196
Slightly volatile
Days Of Sales Outstanding86.5666.763168.2449
Pretty Stable
Cash Flow Coverage Ratios0.470.34760.68
Pretty Stable
Price To Book Ratio2.11.10821.7516
Slightly volatile
Fixed Asset Turnover5.463.63884.5847
Slightly volatile
Capital Expenditure Coverage Ratio1.763.37692.45
Slightly volatile
Price Cash Flow Ratio15.1215.521325.5525
Pretty Stable
Debt Ratio0.240.14480.1369
Slightly volatile
Cash Flow To Debt Ratio0.470.34760.68
Pretty Stable
Price Sales Ratio3.363.19773.2562
Slightly volatile
Asset Turnover0.230.24420.4588
Slightly volatile
Gross Profit Margin0.630.52010.554
Very volatile
Price Fair Value2.11.10821.7516
Slightly volatile

Bio Rad Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap919.2 M875.4 M914 M
Slightly volatile
Enterprise ValueB952.4 M995.4 M
Slightly volatile

Bio Fundamental Market Drivers

Forward Price Earnings32.7869
Cash And Short Term Investments1.5 B

Bio Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bio Rad Financial Statements

Bio Rad investors utilize fundamental indicators, such as revenue or net income, to predict how Bio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue41.1 B43.2 B
Total Revenue2.6 B1.4 B
Cost Of Revenue1.2 B643.6 M
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.42  0.43 
Research And Ddevelopement To Revenue 0.10  0.08 
Capex To Revenue 0.06  0.07 
Revenue Per Share 94.75  99.49 
Ebit Per Revenue 0.10  0.08 

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bio Stock

  0.9A Agilent Technologies Earnings Call This WeekPairCorr
  0.8GSS Genetic SignaturesPairCorr

Moving against Bio Stock

  0.55MLAB Mesa LaboratoriesPairCorr
  0.51CTE CryositePairCorr
  0.31OBD Oxford Biodynamics PLCPairCorr
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out the analysis of Bio Rad Correlation against competitors.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Will Life Sciences Tools & Services sector continue expanding? Could Bio diversify its offerings? Factors like these will boost the valuation of Bio Rad. Projected growth potential of Bio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bio Rad data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.83)
Earnings Share
28.43
Revenue Per Share
94.689
Quarterly Revenue Growth
0.039
Return On Assets
0.0167
Bio Rad Laboratories's market price often diverges from its book value, the accounting figure shown on Bio's balance sheet. Smart investors calculate Bio Rad's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Bio Rad's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bio Rad's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bio Rad should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.